BAYER CAT WORMER FILM-COATED TABLETS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
25-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PRAZIQUANTEL PYRANTEL EMBONATE
Available from:
Bayer Limited
ATC code:
QP52AA51
Dosage:
230/20.0 Milligram
Pharmaceutical form:
Tablets
Therapeutic group:
Endoparasiticide
Therapeutic area:
Feline
Authorization date:
2009-03-20
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA:10021/054/001
Case No: 7004270
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
BAYER LIMITED
ANIMAL HEALTH DIVISION, THE ATRIUM, DUBLIN 18, IRELAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
BAYER CAT WORMER FILM-COATED TABLETS
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in Part 2 of the said Schedule.
This authorisation,unless previously revoked, shall continue in force from 20/03/2009 to 19/03/2014.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 25/03/2009_
_CRN 7004270_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bayer Cat Wormer Film-Coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet
White to yellowish scored coated tablet.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of gastrointestinal roundworms and tapeworms:
_Toxocara cati, Toxascaris leonina, Dipylidium caninum, Taenia taeniaeformis_.
4.3 CONTRAINDICATIONS
Do not use simultaneously with piperazine
Read the complete document
